Geriatrics & gerontology international · 2026
An 11-Protein Plasma Proteomic Signature Associated With Incident Dementia Risk in the UK Biobank.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Yang Simin, Wang Zhihong, Wu Yanqi, Feng Hehan, Yang Zongzong, Yang Yuyu
Аннотация
AIM: To derive a compact plasma proteomic signature associated with incident dementia and evaluate the internal performance of the finalized score in UK Biobank.
METHODS: In this prospective cohort study, we screened 2923 baseline Olink assays using Cox models adjusted for age, age squared, sex, and the first 10 genetic principal components. Proteins passing false-discovery-rate control underwent 2- and 5-year landmark analyses, correlation-based redundancy pruning, and repeated stability-based feature selection. The finalized score was evaluated in basic and extended clinical models, a chronological subgroup performance assessment, proportional-hazards testing, and landmark sensitivity analyses.
RESULTS: Among 36 696 participants (mean age 56.84 years; 591 incident dementia events; median follow-up 15.73 years), the final 11-protein score was associated with incident dementia (hazard ratio per 1-SD increase, 2.645; 95% confidence interval, 2.459-2.845) and increased Harrell's C-index from 0.798 to 0.862. In the extended clinical cohort (23 179 participants; 441 events), C-index increased from 0.792 to 0.861. In the later chronological subset (6954 participants; 97 events), C-index increased from 0.801 to 0.869. Associations persisted in the 2- and 5-year landmark analyses, and no statistically significant score-specific violation of the proportional-hazards assumption was detected (p = 0.105).
CONCLUSIONS: A broad plasma proteomic screen yielded a compact 11-protein signature that was strongly associated with incident dementia and showed consistent internal performance after the score had been finalized. Independent external validation is required before clinical use.
METHODS: In this prospective cohort study, we screened 2923 baseline Olink assays using Cox models adjusted for age, age squared, sex, and the first 10 genetic principal components. Proteins passing false-discovery-rate control underwent 2- and 5-year landmark analyses, correlation-based redundancy pruning, and repeated stability-based feature selection. The finalized score was evaluated in basic and extended clinical models, a chronological subgroup performance assessment, proportional-hazards testing, and landmark sensitivity analyses.
RESULTS: Among 36 696 participants (mean age 56.84 years; 591 incident dementia events; median follow-up 15.73 years), the final 11-protein score was associated with incident dementia (hazard ratio per 1-SD increase, 2.645; 95% confidence interval, 2.459-2.845) and increased Harrell's C-index from 0.798 to 0.862. In the extended clinical cohort (23 179 participants; 441 events), C-index increased from 0.792 to 0.861. In the later chronological subset (6954 participants; 97 events), C-index increased from 0.801 to 0.869. Associations persisted in the 2- and 5-year landmark analyses, and no statistically significant score-specific violation of the proportional-hazards assumption was detected (p = 0.105).
CONCLUSIONS: A broad plasma proteomic screen yielded a compact 11-protein signature that was strongly associated with incident dementia and showed consistent internal performance after the score had been finalized. Independent external validation is required before clinical use.